Binh Duong OPC Pharmaceutical One Member Co., Ltd.
Binh Duong OPC Pharmaceutical One Member Co., Ltd.
🇻🇳 Vietnam, Binh Duong
200711-50 peopleManufacturer/Distributor/Service Company/WholesalerBinh Duong OPC Pharmaceutical One Member Co., Ltd. is a prominent Vietnamese pharmaceutical manufacturer and distributor established in 2007. As a key subsidiary of the OPC Pharmaceutical Joint Stock Company, the firm operates a state-of-the-art 5.7-hectare production facility in Binh Duong that adheres to rigorous international standards, including GMP-WHO, GLP, GSP, and ISO 9001:2000. The company specializes in the research, development, and production of a wide range of pharmaceutical products, with a particular focus on leveraging Vietnam's herbal potential through GACP-WHO certified medicinal plant cultivation.
OEM manufacturerOffers OEM services for customized brand manufacturing.
Own brandOwns and operates its own brands and manufacturing facilities.
High-tech enterpriseRecognized as a high-tech or innovative enterprise.
Contact
******************
1
*******************
1
Products
THUỐC HO NGƯỜI LỚN OPC
THUỐC HO TRẺ EM OPC
VIÊN NGẬM DƯỠNG THANH OPC
TRÀ TÚI LỌC RUTON
SANOLIN 20 SÂM NGỌC LINH YẾN SÀO
SÂM NGỌC LINH YẾN SÀO OPC
SANOLIN 20
MIMOSA VIÊN AN THẦN
DẦU KHUYNH DIỆP OPC
VIÊN XÔNG EUCA – OPC
HOASTEX®
KIM TIỀN THẢO OPC (bao phim)
Customers
VINA COSMO
**********
*********
******
**********************
Unlock all 10 customers
Certifications
GMP1
GS1
ISO 90011
Ask AI about this supplier
Key export market
Shipments
Shipments count
0
Export volume
0 kg
Export countries
0
Customers
0
Insights
Top 5 customers
Reflecting the depth of cooperation between supplier and customersTop 5 customers
This insight is only available in the Pro planTop 5 export countries
Reflecting the supplier's export experience in target countriesTop 5 export countries
This insight is only available in the Pro planShipment count distribution
Reflecting the supplier's market business activityAll categories
Shipment count distribution
This insight is only available in the Pro planExport weight distribution (kg)
Reflecting the supplier's export scaleAll categories
Export weight distribution (kg)
This insight is only available in the Pro planExport weight trend (kg)
Reflecting the growth rate of the supplier's phased total supply volume and the fluctuation of supply volume, identifying supply peaks and troughsAll categories
Export weight trend (kg)
This insight is only available in the Pro planCIF trend (USD)
For identifying high-value cooperation periods and single order value changesAll categories
CIF trend (USD)
This insight is only available in the Pro planSimilar suppliers you may like
VCP Pharmaceutical Joint Stock Company
🇻🇳 Vietnam
2003101-200 peopleManufacturer/Trading Company/Wholesaler/DistributorEstablished brand
Multinational enterprise
OEM manufacturer
Shipments
9
Key customer
WALMART
Key market
🇨🇳 China
Description
VCP Pharmaceutical Joint Stock Company is a prominent pharmaceutical manufacturer and trader headquartered in Hanoi, Vietnam. Established in 2003 as a joint venture and evolving into a joint stock company in 2008, the organization operates a sophisticated production facility in Soc Son, Hanoi. The company is a leading specialist in the production of powder antibiotics for injection, specifically within the Penicillin and Cephalosporin groups. Its manufacturing capabilities are supported by two dedicated workshops equipped with advanced, automated systems that comply with World Health Organization Good Manufacturing Practice (GMP-WHO) standards. Beyond its core antibiotic lines, the company offers a diverse portfolio including topical medicines (creams, ointments, and gels), herbal medicines, traditional remedies, and functional foods. VCP Pharmaceutical Joint Stock Company serves a broad market by distributing products to hospitals and pharmacies across Vietnam, supported by sales offices in both Hanoi and Ho Chi Minh City. The company also maintains robust international trade operations, engaging in the import of active pharmaceutical ingredients (APIs) and raw materials from global suppliers to support its manufacturing and OEM services. With a workforce of over 100 employees, the company integrates research and development with large-scale production to provide high-quality healthcare solutions including medicinal chemicals, dietary supplements, and specialized pharmaceutical packaging.
Cảm lạnh, đau rát họng, đau nhức mình mẩy
antibiotics, topical medicines, and herbal remedies
VCP Pharmaceutical Joint Stock Company
VCP Pharmaceutical Joint Stock Company Factory
Benadyl
ICA Biotechnological & Pharmaceutical Joint Stock Company
🇻🇳 Vietnam
1999501-1000 peopleManufacturer/Distributor/Wholesaler/Service CompanyHigh capacity factory
Established brand
Own brand
High-tech enterprise
Key market
🇯🇵 Japan
Description
ICA Biotechnological & Pharmaceutical Joint Stock Company is a leading manufacturer and distributor of pharmaceutical and biotechnological products based in Thuan An, Binh Duong, Vietnam. Established in 1995 as a distribution firm, the company transitioned to manufacturing in 1999 and currently operates a large-scale production facility with a workforce of 501 to 1000 employees. The company maintains a robust quality management system with certifications including Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), and Good Storage Practice (GSP).
ICA specializes in a diverse range of therapeutic areas, producing tablets, capsules, and sachets. Its extensive product portfolio includes essential medicines for cardiovascular diseases, diabetes, high cholesterol, and gastric ulcers, as well as specialized treatments such as anti-HIV medications, analgesics, and anti-inflammatory drugs. Notable proprietary and licensed brands include Tobicom (eye supplements), Adagrin (erectile dysfunction treatment), Coxlec, Fortec, and Liponil 10. Beyond human health, the company also provides veterinary preparations and health supplements.
As a vertically integrated enterprise, ICA offers OEM services and manages a comprehensive supply chain serving hospitals, pharmacies, and clinics. While maintaining a strong domestic presence in Vietnam through its Hanoi and Ho Chi Minh City offices, the company is active in international trade, exporting to Southeast Asia and Japan, with strategic expansion plans for the US market. The company is recognized for its commitment to mobilizing advanced technology and capital to support its growth as a major player in the regional pharmaceutical sector.
Caricin 500 (Clarithromycin 500 mg)
Normostat (10) (Atorvastatin 10 mg)
Caricin 250 (Clarithromycin 250mg)
Neumomicid 1.5 (Spiramycin 1.5 MIU)
Liponil (10) (Simvastatin 10 mg)
Adagrin (Sildenafil 50 mg)
Neumomicid 3.0 (Spiramycin 3.0 MIU)
Bididi (Biphenyl dimethyl dicarboxylate 25 mg)
Dudine (Ranitidine 150 mg)
Muxystine (Acetylcysteine 200 mg)
B-Nagen 200 (Nimesulide 100 mg)
B-Nagen 100 (Nimesulide 100 mg)
